About Us

Our study group formed by the collaboration of clinical research groups and international collaborators including pharma experts in the interest of sharing new data in a unique platform through conferences and meetings with the aim of studying MASLD and related pathologies Metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD) is currently the most common liver disorder both in the US and Europe. The fatty liver may progress to non-alcoholic steatohepatitis (NASH, now MASH), which markedly increases the risk of cirrhosis and hepatocellular carcinoma. MASLD is the hepatic manifestation of the metabolic syndrome and characterizes the majority of patients with type 2 diabetes.

Objectives

1. To advance our understanding of the prevalence, diagnosis, pathogenesis, prevention and treatment of MASLD.

2. To enable hepatologists and diabetologists and other specialists in cognate disciplines to interact.

Join us !

We encouraged researchers in the field of diabetes and cardiovascular complications to join the study group a productive way to share your new research with us. Fill out this form to request membership (no fee is requested). Members have the right to participate in all our events.

Our Group

Amalia Gastaldelli - Chair
Research Director of Cardiometabolic Risk Unit, Institute of Clinical Physiology, CNR.
Pisa, Italy
Hannele Yki-Jarvinen - Vice-Chair
Department of Medicine, University of Helsinki, Helsinki University Hospital.
Helsinki, Finland
Christopher Byrne - Member
Nutrition and Metabolism, Faculty of Medicine, University of Southampton ; Southampton National Institute for Health Research, Biomedical Research Centre.
Southampton, UK
Catherine Postic - Member
Université de Paris, Institut Cochin, CNRS, INSERM.
Paris, France
Bart Staels - Member
University Lille, Inserm, CHU de Lille, U1011-EGID, Institut Pasteur de Lille.
Lille, France
Paula Macedo - Member
CEDOC, NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa.
Lisboa, Portugal
Stefano Romeo - Member
Department of Molecular and Clinical Medicine, The Sahlgrenska Academy, University of Gothenburg.
Gothenburg, Sweden